Skip to main content

Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy

The Original Article was published on 15 January 2014

Correction

After the publication of this work [1] it was brought to the authors’ attention that Figures six (Figure 1 here) (E) and (F) contained an error in their data presentation. The correct figure is given below.

Figure 1
figure 1

The tumor-suppressive and chemosensitivity functions of miR-34a were mediated by reduction the production of CD44. Downregulation of CD44 by siRNA led to similar effect of miR-34a overexpression on A) cell proliferation (mean ± SEM; n = 3; *p < 0.05) and B-C) tumorigenity (mean + SEM; n = 3; *p < 0.05). Increased CD44 expression could efficiently reverse the effect of miR-34a on MIBC D) cell proliferation (mean ± SEM; n = 3; *p < 0.05), E-F) colongenic potential and G) chemosensitivity (mean + SEM; n = 3; *p < 0.05).

We regret any inconvenience that this inaccuracy may have caused.

References

  1. Heng L, Gan Y, Runlin S, Bin L, Xianguo C, Ding X, Haibing X, Xiaolin G, Wei G, Zhangqun Y, Wei X, Hua X: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Molecular Cancer. 2014, 13: 8- 10.1186/1476-4598-13-8

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Wei Xiao or Hua Xu.

Additional information

The online version of the original article can be found at 10.1186/1476-4598-13-8

Heng Li, Gan Yu contributed equally to this work.

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Li, H., Yu, G., Shi, R. et al. Erratum To: Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy. Mol Cancer 13, 183 (2014). https://doi.org/10.1186/1476-4598-13-183

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/1476-4598-13-183